Baxter International | BAX - Assets



Baxter International reported $21.3B in Assets for its fiscal quarter ending in March of 2025.


Assets Change Date
Abbott USD 84B 2.55B Jun/2025
AtriCure USD 608.85M 17.22M Jun/2025
Avanos Medical USD 1.04B 68.8M Jun/2025
Baxter International USD 21.3B 4.48B Mar/2025
Becton, Dickinson and Co. USD 54.9B 435M Jun/2025
Boston Scientific USD 40.14B 745M Mar/2025
Cooper Companies USD 12.38B 36.9M Jul/2025
Dexcom USD 7.33B 575.3M Jun/2025
Edwards Lifesciences USD 13.02B 33M Mar/2025
Fresenius EUR 41.32B 1.89B Jun/2025
Globus Medical USD 4.96B 249.94M Jun/2025
Halozyme Therapeutics USD 2.05B 142.63M Jun/2025
ICU Medical USD 4.11B 77.19M Jun/2025
Insulet USD 3.47B 48.1M Jun/2025
Integra LifeSciences USD 3.67B 384.85M Jun/2025
Intuitive Surgical USD 20.16B 942.8M Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Laboratory Of America USD 18.06B 456.1M Jun/2025
Masimo USD 2.4B 109.5M Jun/2025
Medtronic USD 91.68B 1.71B Apr/2025
Merit Medical Systems USD 2.59B 118.07M Jun/2025
Quest Diagnostics USD 15.97B 172M Jun/2025
Smith & Nephew USD 10.69B 338M Jun/2025
Stryker USD 46.33B 325M Jun/2025
Tandem Diabetes Care USD 875.74M 46.41M Jun/2025
Teleflex USD 7.38B 211.93M Jun/2025
Terumo JPY 1.8T 28.96B Jun/2025
Zimmer Biomet Holdings USD 22.87B 681.2M Jun/2025